allogeneic nicotinamide-expanded natural killer cells
Term · Oncology and biomedicine · MLC-T-ONC-009931
Allogeneic, nicotinamide (NAM)-expanded natural killer (NK) cells, with potential cytolytic and antineoplastic activities. Upon administration, the allogeneic NAM-expanded NK cells may lyse cancer cells. These cells also secrete pro-inflammatory cytokines, which further stimulate an anti-tumor immune response. Ex-vivo treatment with the vitamin B3 derivative NAM increases the in-vivo homing, retention and proliferation potential of the NK cells.
| Identifier | MLC-T-ONC-009931 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | allogeneic NAM NK cells; allogeneic NAM NKs; donor nicotinamide-expanded natural killer cells |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-009931",
"term": "allogeneic nicotinamide-expanded natural killer cells",
"field": "Oncology and biomedicine",
"definition": "Allogeneic, nicotinamide (NAM)-expanded natural killer (NK) cells, with potential cytolytic and antineoplastic activities. Upon administration, the allogeneic NAM-expanded NK cells may lyse cancer cells. These cells also secrete pro-inflammatory cytokines, which further stimulate an anti-tumor immune response. Ex-vivo treatment with the vitamin B3 derivative NAM increases the in-vivo homing, retention and proliferation potential of the NK cells.",
"synonyms": [
"allogeneic NAM NK cells",
"allogeneic NAM NKs",
"donor nicotinamide-expanded natural killer cells"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/allogeneic-nicotinamide-expanded-natural-killer-cells/"
}
Record 817 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.